3i Group share price dips after Action sales update — and a £1bn stake deal lands
30 January 2026
1 min read

3i Group share price dips after Action sales update — and a £1bn stake deal lands

London, Jan 30, 2026, 08:52 GMT — Regular session

  • 3i shares slip slightly in early trading following a strong surge on Thursday
  • Company aims to boost its holding in Action by issuing new shares
  • Investors are focused on the deal closing and the upcoming Action update scheduled for March

Shares of 3i Group (III.L) dipped early Friday in London, falling around 1.2% to about 3,384 pence, after finishing the previous session at 3,423 pence. 1

The jump follows a day when 3i climbed 8.8%, topping the FTSE 100 gainers after investors reacted positively to what Reuters called a robust third-quarter update.

3i’s latest update showed net asset value per share climbed to 3,017 pence at Dec. 31, up from 2,857 pence at Sept. 30. The company reported a 20% total return over the first nine months of its financial year. It highlighted Action’s like-for-like sales growth at 4.9% for 2025 and 6.1% in the first four weeks of 2026, with France posting a 2.1% increase in that early period. 3i also announced plans to acquire an additional 2.9% of Action from Singapore’s GIC by issuing 31,353,859 new shares valued at £1 billion, boosting its stake to 65.3%. The deal is expected to complete and start trading on Friday. CEO Simon Borrows described the group’s progress as a “good start” to the final quarter. 2

“January got off to a strong start,” Bernstein retail analyst William Woods noted in a report, highlighting the uptick in sequential trading. 3

Borrows snapped up 30,000 shares of 3i on Thursday, paying £34.897837 each, according to a regulatory filing. 4

For months, traders have used 3i as a stand-in for Action, causing the stock to react sharply to any sign of slumping retail demand. The early drop on Friday felt more like a pause to absorb news than a full-blown sell-off.

That said, the structure is key. Raising exposure by issuing stock ties returns directly to Action’s performance, leaving little wiggle room if the sales rebound in France falters.

The downside is straightforward: if consumers tighten their belts, promotions ramp up, or France delivers another uneven quarter, same-store sales will reflect it fast—and so will 3i’s portfolio value.

Investors will spend the remainder of Friday watching to see if the share issuance has gone through as expected and if the stock can extend Thursday’s gains instead of slipping back into its recent trading range.

Mark March 26 on your calendar: 3i is hosting an Action Capital Markets Seminar webcast. 5

Stock Market Today

Thermo Fisher stock holds near $543 after Thursday slide as traders size up layoffs notice, data week ahead

Thermo Fisher stock holds near $543 after Thursday slide as traders size up layoffs notice, data week ahead

8 February 2026
cNew York, Feb 7, 2026, 17:29 EST — Market closed. Thermo Fisher Scientific (TMO.N) shares ended Friday, Feb. 6, at $542.83, steady on the day after a roughly 4% drop in the prior session. With U.S. markets shut on Saturday, traders head into Monday looking for signs the selloff has run its course. 1 The stock has been jumpy because the company sits at the intersection of two messy lines: research spending that can disappear fast, and drugmakers’ demand for tools and services that tends to hold up. That split matters now because the next leg, up or down, may
Disney stock ends week higher after Friday bounce — what to watch for DIS next week

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

7 February 2026
Disney shares closed up 3.6% at $108.70 Friday, recovering from earlier losses as U.S. stocks rallied and the Dow topped 50,000. Investors are watching Super Bowl streaming economics and Disney’s CEO transition, with Josh D’Amaro set to take over at the March 18 meeting. Disney reported quarterly revenue of $25.98 billion and adjusted EPS of $1.63, while segment operating income fell 9% to $4.6 billion.
Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

7 February 2026
Novo Nordisk Class B shares closed up 5.3% at 295.50 Danish crowns in Copenhagen after Hims & Hers said it would stop offering a compounded pill version of Wegovy following U.S. regulatory warnings. The move came after Novo called the Hims product “illegal mass compounding” and threatened legal action. Shares had fallen nearly 8% Thursday after Hims launched the pill. Trading resumes Monday.
Barclays share price rises on buyback update — traders circle Feb. 10 results
Previous Story

Barclays share price rises on buyback update — traders circle Feb. 10 results

Prudential plc stock ticks up after Malaysia stake deal closes as buyback rolls on
Next Story

Prudential plc stock ticks up after Malaysia stake deal closes as buyback rolls on

Go toTop